We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPLK
301
DELISTED
Splunk Inc
SPLK
| $37.6M | 0.07% |
252,997
-292,474
| -54% | -$35.8M |
|
302
Cenovus Energy
CVE
$54.6B
| $37.5M | 0.07% |
2,248,169
-998,197
| -31% | -$15.1M |
|
303
CF Industries
CF
$19.2B
| $37.3M | 0.07% |
361,514
-555,318
| -61% | -$44.8M |
|
|
APGB
304
DELISTED
Apollo Strategic Growth Capital II
APGB
| $37.2M | 0.07% |
3,797,333
+433,386
| +13% | +$4.23M |
|
305
Ciena
CIEN
$55.3B
| $36.9M | 0.07% |
608,947
+454,418
| +294% | +$29.7M |
|
306
Vail Resorts
MTN
$5.19B
| $36.8M | 0.07% |
141,463
+136,115
| +2,545% | +$37M |
|
307
Shopify
SHOP
$148B
| $36.8M | 0.07% |
+544,510
| New | +$44.7M |
|
308
Stratasys
SSYS
$697M
| $36.8M | 0.07% |
1,449,445
+348,986
| +32% | +$8.42M |
|
309
Teledyne Technologies
TDY
$30.4B
| $36.8M | 0.07% |
77,818
+15,057
| +24% | +$6.48M |
|
310
T-Mobile US
TMUS
$193B
| $36.7M | 0.07% |
285,943
-629,597
| -69% | -$75M |
|
311
Hewlett Packard
HPE
$63.2B
| $36.7M | 0.07% |
2,194,037
+942,369
| +75% | +$15.8M |
|
|
ANSS
312
DELISTED
Ansys
ANSS
| $36.5M | 0.07% |
114,865
-2,558
| -2% | -$835K |
|
|
SMAR
313
DELISTED
Smartsheet Inc.
SMAR
| $36.5M | 0.07% |
665,560
+333,302
| +100% | +$19M |
|
314
Corteva
CTVA
$59.7B
| $36.4M | 0.07% |
633,850
+627,418
| +9,755% | +$32.1M |
|
315
Bunge Global
BG
$23.6B
| $36.3M | 0.07% |
327,575
+278,066
| +562% | +$28.5M |
|
316
CALL
Berkshire Hathaway Class B
BRK.B
$1.07T
| $35.7M | 0.07% |
101,200
+90,600
| +855% | +$29.3M |
|
|
CONX
317
DELISTED
CONX Corp. Class A Common Stock
CONX
| $35.6M | 0.07% |
3,618,769
| – | – |
|
318
WEC Energy
WEC
$37.7B
| $35.5M | 0.07% |
355,937
+355,558
| +93,815% | +$33.6M |
|
319
SM Energy
SM
$7.96B
| $35.5M | 0.07% |
+910,391
| New | +$32.8M |
|
320
Cigna
CI
$76.6B
| $35.5M | 0.07% |
147,983
+147,940
| +344,047% | +$34.6M |
|
321
Oracle
ORCL
$331B
| $35.3M | 0.07% |
+427,168
| New | +$34.6M |
|
322
Ford
F
$57.3B
| $35.2M | 0.07% |
2,083,765
-834,270
| -29% | -$15.9M |
|
323
Netflix
NFLX
$292B
| $35.1M | 0.07% |
938,240
-688,930
| -42% | -$28.7M |
|
324
Jackson Financial
JXN
$8.32B
| $35.1M | 0.07% |
793,221
+281,400
| +55% | +$11.7M |
|
|
CCXI
325
DELISTED
ChemoCentryx, Inc.
CCXI
| $35.1M | 0.07% |
1,398,583
+569,585
| +69% | +$16M |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.